Marc Andre, MD PhD

Université catholique de Louvain, CHU UCL Namur
Department of Hematology
Yvoir Belgium Papers:
227 Single-Arm Phase II Study of MOR208 Combined with Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: L-Mind
2836 Unraveling the Landscape of Copy Number Aberrations in Hodgkin Lymphoma: A Joint KU Leuven and Lysa Study on Circulating Cell Free DNA